These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 35397331)

  • 1. Antiviral potential of nanoparticles for the treatment of Coronavirus infections.
    Sarkar J; Das S; Aich S; Bhattacharyya P; Acharya K
    J Trace Elem Med Biol; 2022 Jul; 72():126977. PubMed ID: 35397331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Nanomaterials against Coronaviruses.
    Muhammad W; Zhai Z; Gao C
    Macromol Biosci; 2020 Oct; 20(10):e2000196. PubMed ID: 32783352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
    Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
    Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
    Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
    Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
    Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.
    Khazir J; Maqbool T; Mir BA
    Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
    J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review.
    Das C; Paul SS; Saha A; Singh T; Saha A; Im J; Biswas G
    Int J Nanomedicine; 2020; 15():9301-9315. PubMed ID: 33262589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.
    Shagufta ; Ahmad I
    Eur J Med Chem; 2021 Mar; 213():113157. PubMed ID: 33486200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus.
    Narayanan D; Parimon T
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
    Lisi L; Lacal PM; Barbaccia ML; Graziani G
    Biochem Pharmacol; 2020 Oct; 180():114169. PubMed ID: 32710969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effects of coinage metal-based nanomaterials to combat COVID-19 and its variants.
    Mushtaq A; Iqbal MZ; Kong X
    J Mater Chem B; 2022 Jul; 10(28):5323-5343. PubMed ID: 35775993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.